Invention Grant
- Patent Title: Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG
-
Application No.: US15791947Application Date: 2017-10-24
-
Publication No.: US10053691B2Publication Date: 2018-08-21
- Inventor: Joseph Collard , Olga Khorkova Sherman
- Applicant: CuRNA, Inc.
- Applicant Address: US FL Miami
- Assignee: CuRNA, Inc.
- Current Assignee: CuRNA, Inc.
- Current Assignee Address: US FL Miami
- Agency: CuRNA, Inc.
- Agent Monte R. Browder
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12N15/113 ; A61K31/713 ; C07H21/04
Abstract:
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of NANOG, in particular, by targeting natural antisense polynucleotides of NANOG. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of NANOG.
Public/Granted literature
- US20180037891A1 TREATMENT OF NANOG RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO NANOG Public/Granted day:2018-02-08
Information query
